CCR antagonist BMS-813160, Purity ≥98%

Synonym: BMS-813160; 1286279-29-5; BMS813160; BMS 813160; BMS 813160 - Bio-X; 83U7957287; N-((1R,2S,5R)-5-((1,1-Dimethylethyl)amino)-2-((3S)-3-((7-(1,1-dimethylethyl)pyrazolo(1,5-a)-1,3,5-triazin-4-yl)amino)-2-oxo-1-pyrrolidinyl)cyclohexyl)-Acetamide; CCR antagonist

CAS Number: 1286279-29-5
Compound CID: 51039119

Product Size

2 mg; 5 mg; 10 mg; 25 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

BMS-813160, soluble in DMSO and ethanol and insoluble in water, stimulates CCR receptors. The receptors bind to chemokines, which are signaling proteins that direct the migration of immune cells to sites of inflammation, infection, or injury.

Molecular Weight

484.65

Molecular Formula

C₂₅H₄₀N₈O₂

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 92 mg/mL (189.82 mM); Water: Insoluble; Ethanol: 92 mg/mL (189.82 mM)

Identity

Confirmed by NMR/HPLC/MS.

Applications

BMS-813160 is studied as a CCR2/5 antagonist with potential applications in cancer immunotherapy and fibrosis research.